Safe use of long-acting β-agonists: what have we learnt?

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.5, 2011-09, pp. : 767-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting β-Agonists in Asthma Management: What is the Current Status?

By Mysore Satya

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2091-2097

Adis International

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

New long-acting β₂-agonists

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1385-1388

Informa Healthcare

Access to resources Recommend Favorite

New long acting β₂ agonists

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 273-277

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting Opioid-Agonists in the Treatment of Heroin Addiction: Why Should We Call Them “Substitution”?

By Gerra G. Maremmani I. Capovani B. Somaini L. Berterame S. Tomas-Rossello J. Saenz E. Busse A. Kleber H.

Substance Use & Misuse, Vol. 44, Iss. 5, 2009-04 ,pp. : 663-671

Informa Healthcare

Access to resources Recommend Favorite